Short-term course of chronic hepatitis B and c under treatment with etanercent associated with different disease modifying antirheumatic drugs without antiviral prophylaxis

Cansu D. U., Kasifoglu T., KORKMAZ C.

JOURNAL OF RHEUMATOLOGY, vol.35, no.3, pp.421-424, 2008 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 35 Issue: 3
  • Publication Date: 2008
  • Journal Name: JOURNAL OF RHEUMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.421-424
  • Keywords: etanercept, hepatitis B, hepatitis c, rheumatoid arthritis, anti-tumor necrosis factor-alpha, RHEUMATOID-ARTHRITIS, LIVER-TRANSPLANTATION, INFLIXIMAB THERAPY, VIRUS-INFECTION, ALPHA THERAPY, REACTIVATION, DIAGNOSIS, PATIENT, AGENTS
  • Eskisehir Osmangazi University Affiliated: Yes

Abstract

Objective. To evaluate the short-term course of chronic hepatitis B and C under treatment with etanercept (ETN) associated with different disease modifying antirheumatic drugs (DMARD).